Nn Petrov National Medical Research Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers analyze overall survival rate of prostate cancer patients treated with melatonin Oncotarget recently published Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019. Comprehensive statistical methods were used to analyze the overall survival rate of PCa patients treated with melatonin in various prognosis groups. The overall survival rate of PCa patients with favorable and intermediate prognoses treated or not treated with melatonin was not statistically significantly different. In the poor prognosis group, the median overall survival in patients taking the drug was 153.5 months versus 64.0 months in patients not using it.

Vladimirn anisimovEmily hendersonAnisimov research teamNn petrov national medical research centerOncotargetresearch paperNational medical research centerProstate cancerஎமிலி ஹென்டர்சன்ந் பெட்ரோவ் தேசிய மருத்துவ ஆராய்ச்சி மையம்தேசிய மருத்துவ ஆராய்ச்சி மையம்ப்ராஸ்டேட் புற்றுநோய்